Cargando…

Engineering influenza viral vectors

The influenza virus is a respiratory pathogen with a negative-sense, segmented RNA genome. Construction of recombinant influenza viruses in the laboratory was reported starting in the 1980s. Within a short period of time, pioneer researchers had devised methods that made it possible to construct inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junwei, Arévalo, Maria T., Zeng, Mingtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566024/
https://www.ncbi.nlm.nih.gov/pubmed/22922205
http://dx.doi.org/10.4161/bioe.21950
_version_ 1782258513453514752
author Li, Junwei
Arévalo, Maria T.
Zeng, Mingtao
author_facet Li, Junwei
Arévalo, Maria T.
Zeng, Mingtao
author_sort Li, Junwei
collection PubMed
description The influenza virus is a respiratory pathogen with a negative-sense, segmented RNA genome. Construction of recombinant influenza viruses in the laboratory was reported starting in the 1980s. Within a short period of time, pioneer researchers had devised methods that made it possible to construct influenza viral vectors from cDNA plasmid systems. Herein, we discuss the evolution of influenza virus reverse genetics, from helper virus-dependent systems, to helper virus-independent 17-plasmid systems, and all the way to 3- and 1- plasmid systems. Successes in the modification of different gene segments for various applications, including vaccine and gene therapies are highlighted.
format Online
Article
Text
id pubmed-3566024
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-35660242013-02-13 Engineering influenza viral vectors Li, Junwei Arévalo, Maria T. Zeng, Mingtao Bioengineered Review The influenza virus is a respiratory pathogen with a negative-sense, segmented RNA genome. Construction of recombinant influenza viruses in the laboratory was reported starting in the 1980s. Within a short period of time, pioneer researchers had devised methods that made it possible to construct influenza viral vectors from cDNA plasmid systems. Herein, we discuss the evolution of influenza virus reverse genetics, from helper virus-dependent systems, to helper virus-independent 17-plasmid systems, and all the way to 3- and 1- plasmid systems. Successes in the modification of different gene segments for various applications, including vaccine and gene therapies are highlighted. Landes Bioscience 2013-01-01 /pmc/articles/PMC3566024/ /pubmed/22922205 http://dx.doi.org/10.4161/bioe.21950 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Review
Li, Junwei
Arévalo, Maria T.
Zeng, Mingtao
Engineering influenza viral vectors
title Engineering influenza viral vectors
title_full Engineering influenza viral vectors
title_fullStr Engineering influenza viral vectors
title_full_unstemmed Engineering influenza viral vectors
title_short Engineering influenza viral vectors
title_sort engineering influenza viral vectors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566024/
https://www.ncbi.nlm.nih.gov/pubmed/22922205
http://dx.doi.org/10.4161/bioe.21950
work_keys_str_mv AT lijunwei engineeringinfluenzaviralvectors
AT arevalomariat engineeringinfluenzaviralvectors
AT zengmingtao engineeringinfluenzaviralvectors